Patient-controlled benzodiazepine dose reduction in a community mental health service

Irish Journal of Psychological Medicine

Volumn 22, Issue 2, 2005, Pages 42-45

  Raju, Bangaru ^a   Meagher, David ^a  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE; BROMAZEPAM; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; LORAZEPAM; NITRAZEPAM; TEMAZEPAM; ZOLPIDEM; ZOPICLONE;

ADULT; ANXIETY DISORDER; ANXIETY MANAGEMENT SESSION; ARTICLE; COMMUNITY MENTAL HEALTH; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MENTAL HEALTH SERVICE; PATIENT CONTROLLED DRUG DOSE REDUCTION; PATIENT EDUCATION; PRESCRIPTION; PSYCHOEDUCATION; PSYCHOTHERAPY; TREATMENT REFUSAL;

EID: 20644467485     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700008909     Document Type: Article

References (30)

1. Taylor D, McConnell D, McConnell H, Kerwin R. The South London and Maudsley Trust 2001 Prescribing Guidelines: 6th ed. London: Martin Dunitz, 2001.
2. Royal Pharmaceutical Society of Great Britain. London: Bri National Formulary, 2002.
3. Department of Health and Children. Report of the benzodiazepine committee. Dublin: Government Publications, 2002.
4. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly, effects of half-life, dosage and duation on risk of hip racture. Am J Psychiatry 2001; 158: 892-8.
5. American Psychiatric Association. Benzodiazepine dependence, toxicity and abuse: a task force report. Washington DC: APA, 1990.
6. Oude Voshaar RC, Gorgels WJ, Mol AJ, Couvee JE, van Balkom AJ, Zitman FG. Treatment methods for discontinuation of long-term benzodiazepine use. Ned Tijdschr Geneeskd 2001; 145: 1347-50
7. Ashton CH, Rawlins M D, Tyrer SP (1990). A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. Br J Psychiatry 1990; 157: 232-8.
8. Spiegel DA, Bruce TJ. Benzodiazepines and exposure-based cognitive therapies for panic disorder: conclusions from combined treatment trials. Am J Psychiatry 1997; 154: 773-81.
9. Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioural therapy for patients with panic disorder. Am J Psychiatry 1993; 150: 1485-90.
10. Oude-Voshaar RC, Gorgels WJMJ, Mol AJJ, Van Bolkom AJLM, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry 2003; 182: 498-504.
11. Fraser D, Peterkin GSD, Gamsu CV, Baldwin PJ. Benzodiazepine withdrawal: a pilot comparison of three models. Br J Clinical Psychology 1990; 29: 231-3.
12. Tyrer P, Ferguson B, Hallstrom C, Michie M, Tyrer S, Cooper S, Caplan R, Barczak P. A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms. Br J Psychiatry 1996; 168: 457-61.
13. Zitman FG, Couvee J E. Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off. Br J Psychiatry 2001; 178: 317-24.
14. Linden M, Bar T, Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychological Med 1998; 28: 721-9.
15. Meagher D, Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatric Bulletin 2003; 27: 266-71.
16. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva: WHO, 1993.
17. Bazire S. Psychotropic Drug directory. The professionals pocket handbook and aide memoire. Bath; Bath Press, 2001.
18. Gutierrez-Lobos K, Frohlich S, Quiner S, Haring C, Barnas C. Prescription patterns and quality of information provided for consumers of benzodiazepines. Acta Med Austriaca 2001; 28: 56-9.
19. Van Haaren AM, Lapane KL, Hughes CM. Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents. Pharmacothereapy 2001; 21: 1159-66.
20. Griffith DN, Robinson M. Prescribing practice and policy for hypnotics: a model of pharmacy audit. Age Ageing 1996; 25: 490-2.
21. Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiatry 1991; 158: 511-6.
22. Cormack MA, Sweeney KG, Hughes-Jones H, Foot GA. Evaluation of an easy, cost effective strategy for cutting benzodiazepine use in general practice. Br J Gen Practice 1994; 44: 5-8.
23. Rickeis K, Schweizer E, Case WG, et al. Long-term therapeutic use of benzodiazepines I: effects of abrupt discontinuation. Arch Gen Psychiatry 1990; 47: 899-907.
24. Schweizer E, Rickeis K, Case WG, Greenblatt DJ. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Arch Gen Psychiatry 1991; 48: 448-52.
25. Rickels K, Schweizer E, Garcia Espana F, Case G, DeMartinis N, Greenblatt D. Trazadone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmac 1999; 141: 1;1-5.
26. Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A. Does cognitive therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry 1994; 151: 876-81.
27. Vorma H, Naukkarinen H, Sarna S, Kuoppasalmi K (2003). Long-term outcome after benzodiazepine withdrawal treatment in subjects with complicated dependence. Drug Alcohol Depend 2003; 70(3): 309-14.
28. Golombok S, Higgitt A, Fonagy P, Dodds S, Saper J, Lader M. A follow-up study of patients treated for benzodiazepine dependence. Br J Med Psychol 1987; 60: 141-9.
29. Zitman FG, Couvee JE. 1991
30. Williams DDR, McBride A. Benzodiazepines: time for reassessment. Br J Psychiatry 173: 361-3.